A few major factors are driving new cases of head and neck cancers. Luckily, they are things you can control.

A new study reveals that many oral cancers are no longer driven by traditional risk factors like smoking or Human papillomavirus infection.

CRB-701 targets Nectin-4, delivering chemotherapy directly to cancer cells, minimizing damage to healthy tissue. The FDA's fast track designation aims to expedite CRB-701's development for HNSCC and ...

Head and neck cancers, particularly those originating in the oral cavity, have historically been attributed to well-defined etiological factors like ...

A PD-L1 score for head and neck cancer helps guide treatment decisions, including when immunotherapy may be used. Here’s what your results mean.